Trade ALMS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Alumis Inc. (ALMS) is trading at US$22.58, down 2.71% today as of Aug 28, 13:55 EDT. The company has a market capitalisation of US$3.13B. Over the past 52 weeks, ALMS has traded between US$3.76 and US$31.35. On Syfe you can trade ALMS with $0 commission and add it to your watchlist.
| Previous close | US$23.21 |
|---|---|
| Market cap | US$3.13B |
| 52-week range | US$3.76 – US$31.35 |
| Volume | 478.31K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Alumis Inc.
Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
Year: 2024
Chardan Raises Price Target on Alumis to $40 From $38, Keeps Buy Rating
May 19, 11:59 AM · MT Newswires
Sector Update: Healthcare Stocks Softer Friday Afternoon
May 15, 5:51 PM · MT Newswires
Sector Update: Healthcare Stocks Mixed Premarket Friday
May 15, 1:16 PM · MT Newswires
Alumis Inc. (ALMS) stock is trading at US$22.58, -2.71% from the previous close of US$23.21.
The market cap for Alumis Inc. (ALMS) stock is approximately US$3.13B.
The 52-week high for Alumis Inc. (ALMS) stock is US$31.35.
The 52-week low for Alumis Inc. (ALMS) stock is US$3.76.
Alumis Inc. (ALMS) does not currently pay a dividend.
Stay on top of ALMS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
